Al Altomari
2017
In 2017, Al Altomari earned a total compensation of $1M as Chairman and Chief Executive Officer at Agile Therapeutics, a 29% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $123,600 |
|---|---|
| Option Awards | $367,200 |
| Salary | $492,000 |
| Other | $26,117 |
| Total | $1,008,917 |
Altomari received $492K in salary, accounting for 49% of the total pay in 2017.
Altomari also received $123.6K in non-equity incentive plan, $367.2K in option awards and $26.1K in other compensation.
Rankings
In 2017, Al Altomari's compensation ranked 8,936th out of 14,666 executives tracked by ExecPay. In other words, Altomari earned more than 39.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,936 out of 14,666 | 39th |
Division Manufacturing | 3,415 out of 5,772 | 41st |
Major group Chemicals And Allied Products | 1,165 out of 2,075 | 44th |
Industry group Drugs | 929 out of 1,731 | 46th |
Industry Pharmaceutical Preparations | 731 out of 1,333 | 45th |
Source: SEC filing on April 25, 2018.
Altomari's colleagues
We found two more compensation records of executives who worked with Al Altomari at Agile Therapeutics in 2017.